Calamos Advisors’s Berenson Acquisition Corp. I Warrants, each whole warrant exercisable for one share of class A common stock at an exercise price of $11.50 BACA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-250,000
Closed -$9.13K 1304
2022
Q4
$9.13K Hold
250,000
﹤0.01% 1113
2022
Q3
$13K Buy
+250,000
New +$25.6K ﹤0.01% 1151

Other funds holding BACA.WS

Calamos Advisors's BACA.WS Position: Q1 2023 in Review

Calamos Advisors sold out of Berenson Acquisition Corp. I Warrants, each whole warrant exercisable for one share of class A common stock at an exercise price of $11.50 (BACA.WS) in Q1 2023, closing a stake of 250,000 shares — an estimated $9.13K sold.

Calamos Advisors first reported a position in BACA.WS in Q3 2022 and held it in 2 quarters. The position peaked at $13K in Q3 2022. 8 funds tracked by Wall St. Rank hold BACA.WS as of Q1 2023.

  • Calamos Advisors reported no remaining Berenson Acquisition Corp. I Warrants, each whole warrant exercisable for one share of class A common stock at an exercise price of $11.50 position as of Q1 2023 after selling out during the quarter.
  • Calamos Advisors sold 250,000 Berenson Acquisition Corp. I Warrants, each whole warrant exercisable for one share of class A common stock at an exercise price of $11.50 shares in Q1 2023, an estimated $9.13K.
  • Calamos Advisors first reported a position in Berenson Acquisition Corp. I Warrants, each whole warrant exercisable for one share of class A common stock at an exercise price of $11.50 in Q3 2022 and held it in 2 quarters.
  • Calamos Advisors's Berenson Acquisition Corp. I Warrants, each whole warrant exercisable for one share of class A common stock at an exercise price of $11.50 position peaked at $13K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Berenson Acquisition Corp. I Warrants, each whole warrant exercisable for one share of class A common stock at an exercise price of $11.50 as of Q1 2023.

Based on Calamos Advisors's 13F filing for Q1 2023, filed 4 May 2023.